Role of drug-coated balloons in small-vessel coronary artery disease

Michael Megaly, Marwan Saad, Emmanouil S. Brilakis

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


Percutaneous coronary intervention of small-vessel coronary artery disease (SVD) remains challenging due to difficulties with device delivery and high restenosis rate, even with the use of newer-generation drug-eluting stents. Drug-coated balloons represent an attractive emerging percutaneous coronary intervention option in patients with SVD. Potential advantages of drug-coated balloons in SVD include enhanced deliverability because of their small profile, avoidance of foreign-body implantation, and shorter duration of dual antiplatelet therapy.

Original languageEnglish (US)
Pages (from-to)16-20
Number of pages5
JournalUS Cardiology Review
Issue number1
StatePublished - 2019
Externally publishedYes


  • Coronary artery disease
  • Drug-coated balloons
  • Drug-eluting stents
  • Small-vessel disease

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Role of drug-coated balloons in small-vessel coronary artery disease'. Together they form a unique fingerprint.

Cite this